IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oyster Point Pharma, Inc.

CUSIP: 69242L010 | 1 institutional holders

Quarters

Q2 2020Q1 2020
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2020

VV Manager LLC778,468
0.0% of portfolio›$22.5K
StyleTurnoverLocationFiled
VV Manager LLC
778,468$22.5K0.0%N/AN/ABoston, MA2020-08-04